Bystander activation and autoimmunity

Y Pacheco, Y Acosta-Ampudia, DM Monsalve… - Journal of …, 2019 - Elsevier
The interaction over time of genetic, epigenetic and environmental factors (ie, autoimmune
ecology) increases or decreases the liability an individual would have to develop an …

[HTML][HTML] Aberrant T cell signaling and subsets in systemic lupus erythematosus

T Katsuyama, GC Tsokos, VR Moulton - Frontiers in immunology, 2018 - frontiersin.org
Systemic lupus erythematosus (SLE) is a chronic multi-organ debilitating autoimmune
disease, which mainly afflicts women in the reproductive years. A complex interaction of …

[HTML][HTML] Current prospects of type II interferon γ signaling and autoimmunity

DS Green, HA Young, JC Valencia - Journal of Biological Chemistry, 2017 - ASBMB
Interferon γ (IFNγ) is a pleiotropic protein secreted by immune cells. IFNγ signals through the
IFNγ receptor, a protein complex that mediates downstream signaling events. Studies into …

[HTML][HTML] STAT4: an immunoregulator contributing to diverse human diseases

C Yang, H Mai, J Peng, B Zhou, J Hou… - International journal of …, 2020 - ncbi.nlm.nih.gov
Signal transducer and activator of transcription 4 (STAT4) is a member of the STAT family
and localizes to the cytoplasm. STAT4 is phosphorylated after a variety of cytokines bind to …

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

JM Riggs, RN Hanna, B Rajan, K Zerrouki… - Lupus science & …, 2018 - lupus.bmj.com
Objective We investigated the mechanistic and pharmacological properties of anifrolumab, a
fully human, effector-null, anti-type I interferon (IFN) alpha receptor 1 (IFNAR1) monoclonal …

[HTML][HTML] Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus

C Guo, Q Liu, D Zong, W Zhang, Z Zuo, Q Yu, Q Sha… - Cell Reports, 2022 - cell.com
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, and CD4+ T cells
are known to promote SLE development. Here, we explore heterogeneities in the CD4+ T …

[HTML][HTML] Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …

[HTML][HTML] Resolvin D1 improves the Treg/Th17 imbalance in systemic lupus erythematosus through miR-30e-5p

T Cheng, S Ding, S Liu, X Li, X Tang, L Sun - Frontiers in immunology, 2021 - frontiersin.org
Resolvin D1 (RvD1) prompts inflammation resolution and regulates immune responses. We
explored the effect of RvD1 on systemic lupus erythematosus (SLE) and investigated the …

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?

E Favoino, M Prete, G Catacchio, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is
an important intracellular route through which many different extracellular soluble …

[HTML][HTML] Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus

GC Wu, J Li, RX Leng, XP Li, XM Li, DG Wang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite increasing evidence that long non-coding RNAs (lncRNAs) widely take part in
human diseases, the role of lncRNAs in systemic lupus erythematosus (SLE) is largely …